Compare AdaptHealth Corp (AHCO) vs ARK Innovation ETF (ARKK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs ARK Innovation ETF — how do they compare? AdaptHealth Corp trades at $10.05 (market cap $1.38B), while ARK Innovation ETF trades at $79.42. The key difference: ARK Innovation ETF is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | ARKK | |
|---|---|---|
Market Cap | $1.38B | — |
Sector | Health | — |
52-Week High | $13.38 | $92.50 |
52-Week Low | $8.68 | $63.52 |
Enterprise Value | $3.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
ARK Innovation ETF (ARKK) trades at $83.61, up 2.9% with a bullish technical outlook from moving averages. The ETF faces mixed sentiment with concerns about its 0.75% expense ratio and 37.88% five-year loss, though recent inflows and AI-focused portfolio shifts show renewed investor interest. Tesla's 10% weighting remains a key driver, while technical indicators show overbought short-term RSI but strong trend momentum.
Outlook hinges on ARKK's concentrated bets in disruptive innovation stocks amid AI momentum, but high fees and volatility pose risks. The ETF's performance remains tied to Tesla and Cathie Wood's stock-picking, with current technical strength suggesting near-term upside if support at $82 holds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About ARK Innovation ETF
The fund will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund’s investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The fund may invest in foreign securities listed on foreign exchanges as well as American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). The fund is non-diversified.
Read more on ARKK →
